MedPath

SUN XIAODONG

πŸ‡ͺπŸ‡ΈSpain
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Phase 4
Conditions
Polypoidal Choroidal Vasculopathy
Interventions
Procedure: OCTA plus OCT guided 3+PRN regimen
Procedure: OCT guided 3+PRN regimen
Drug: Anti-VEGF drug
First Posted Date
2020-05-08
Last Posted Date
2020-05-08
Lead Sponsor
Xiaodong Sun
Target Recruit Count
102
Registration Number
NCT04380974
Locations
πŸ‡¨πŸ‡³

Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Phase 4
Conditions
Age-related Macular Degeneration
Interventions
Procedure: Treat-and-Extend regimen
Procedure: Pro Re Nata
First Posted Date
2016-06-16
Last Posted Date
2020-05-19
Lead Sponsor
Xiaodong Sun
Target Recruit Count
141
Registration Number
NCT02802657
Locations
πŸ‡¨πŸ‡³

Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China

πŸ‡¨πŸ‡³

Eye & Ent Hospital of Fudan University, Shanghai, China

πŸ‡¨πŸ‡³

Shanghai Zhongshan Hospital, Shanghai, China

and more 2 locations
Β© Copyright 2025. All Rights Reserved by MedPath